InflaRx N.V. Common Stock
Here’s whether InflaRx N.V. Common Stock (IFRX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.84% over 10 days); strong 1-year return of +51.4%; 3-month momentum positive (+59.0%); rising volume confirms the move (2.06x 30d avg). Concerns: RSI 86 — overbought, elevated pullback risk. Currently 18.0% off its 52-week high. Score: +6/7.
IFRX is in a confirmed uptrend, trading above both its 50-day ($0.95) and 200-day ($1.09) moving averages. With an RSI of 85.6, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +51.4% compares to +35.1% for SPY (beat the market by 16.3%).